Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs EXEL✓SelectedUSD · EXELMRNA vs EXEL performance historyLatest closeAs of-4.84%11/18
Stock and ETF performance explorer

MRNA vs EXEL

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+149.2%
EXEL return
+222.9%
Excess return
-73.7%
Maximum drawdown
-86.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioEXELExcessAlpha
1D-4.8%-0.3%-4.5%-4.7%
7D-20.9%-3.4%-17.5%-19.5%
30D-13.3%+9.0%-22.2%-16.5%
3M+212.6%+28.6%+184.0%+182.9%
6M+309.0%+37.0%+272.0%+264.7%
YTD+567.3%+55.8%+511.5%+473.2%
1Y+689.7%+60.1%+629.6%+574.8%
All+149.2%+222.9%-73.7%+103.0%

Cumulative growth

Daily Returns

Daily percentage return beside EXEL.

Daily Out/Under-Performance

Portfolio return minus EXEL return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × EXEL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded EXEL wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling